Kobi Tzoref
executiveMale0.0Global Dominance: 0.00%
Kobi Tzoref is the CEO of Pharma Israel, an association representing international original drug companies. He has emphasized the importance of regulatory oversight for pharmaceutical distribution companies like Novolog amidst the unprecedented medication shortages affecting patients across Israel.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Kobi Tzoref, CEO of Pharma Israel, welcomed the reliance on international drug registrations as a significant step for Israeli citizens.
מהפכה באישור תרופות בישראל: "שינוי משמעותי, המחיר יירד"ידיעות אחרונות (Yedioth Ahronoth / ynet)·
Israel· 2025-03-26
Israel· 2025-03-26
Kobi Tzoref, CEO of Pharma Israel, emphasized the critical role of Novolog in the drug supply process.
"מטופל חיפש אינסולין, זה לא משחק"ידיעות אחרונות (Yedioth Ahronoth / ynet)·Israel· 2025-02-20
Israel· 2025-02-20
